During a public hearing of a special lower house commission against COVID-19, Foundation Oswaldo Cruz (Fiocruz) Head Nísia Trindade said 1 million doses are scheduled to be delivered in the weeks of February 2–12 and 15–19.
Inspectors await additional data to draft a report. In a note, Anvisa reports that the certificate of good practices in manufacture is ready by the first half of January.
“After evaluating the data on the adverse event, its cause, and the set of security data generated in the study, the agency concluded that the relation benefit-risk is kept favorable, which is why the study will be allowed to resume,” the agency said in a note.